Breast cancer patients who underwent postmastectomy breast reconstruction had lower sexual well-being scores compared with ...

The company has asked the U.S. patent office to reconsider patents that could prevent it from selling a new version of its ...

New research in mice may explain why aspirin seems to lower the risk of people's cancers spreading out of control.

Biotech Halozyme Therapeutics believes the new version of Merck's blockbuster cancer drug Keytruda infringes on its patents, ...

A common type of diabetes medication could help cancer patients make a better long-term recovery, according to new research ...

A new drug that works against the main types of primary bone cancer has been developed by researchers at the University of ...

Striking study results last year indicated a new type of medicine may improve on Merck’s immunotherapy, spurring a wave of ...

Merck's injected version of its blockbuster cancer drug Keytruda could face a potential patent challenge from biotech ...

Can a drug that's used to treat malaria be repurposed to fight cancer? Researchers at The University of Texas at El Paso have ...

Dr. Jie Yang, who carried out the researchm described the drug as a less expensive solution that is more accessible globally.

The groundbreaking study demonstrates drug candidate can safely and effectively target and eliminate senescent cells, also known as “zombie cells,” from the liver.